Serology, or antibody, tests promise to be one of the key tools in tracking and stopping the spread of COVID-19. But some manufacturers may be taking advantage of the ongoing pandemic by making misleading claims in their test marketing, the FDA warned in two recent statements.
The tests detect COVID-19 antibodies in the blood. They help identify people who have had the virus and recovered, developing antibodies that may protect them from future infection, FDA commissioner...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?